01 1Uquifa Italia S.p.A. Agrate Brianza IT
01 1Carisoprodol - Monograph Text deleted 01/07/2020
01 1Spain
01 1Expired
Carisoprodol - Monograph Text Deleted 01/07/2020
Certificate Number : R0-CEP 2004-128 - Rev 00
Status : Expired
Issue Date : 2008-05-14
Type : Chemical
Substance Number : 1689
79
PharmaCompass offers a list of Carisoprodol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carisoprodol manufacturer or Carisoprodol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carisoprodol manufacturer or Carisoprodol supplier.
PharmaCompass also assists you with knowing the Carisoprodol API Price utilized in the formulation of products. Carisoprodol API Price is not always fixed or binding as the Carisoprodol Price is obtained through a variety of data sources. The Carisoprodol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CARISOPRODOL [USP MONOGRAPH] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CARISOPRODOL [USP MONOGRAPH], including repackagers and relabelers. The FDA regulates CARISOPRODOL [USP MONOGRAPH] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CARISOPRODOL [USP MONOGRAPH] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CARISOPRODOL [USP MONOGRAPH] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CARISOPRODOL [USP MONOGRAPH] supplier is an individual or a company that provides CARISOPRODOL [USP MONOGRAPH] active pharmaceutical ingredient (API) or CARISOPRODOL [USP MONOGRAPH] finished formulations upon request. The CARISOPRODOL [USP MONOGRAPH] suppliers may include CARISOPRODOL [USP MONOGRAPH] API manufacturers, exporters, distributors and traders.
click here to find a list of CARISOPRODOL [USP MONOGRAPH] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CARISOPRODOL [USP MONOGRAPH] CEP of the European Pharmacopoeia monograph is often referred to as a CARISOPRODOL [USP MONOGRAPH] Certificate of Suitability (COS). The purpose of a CARISOPRODOL [USP MONOGRAPH] CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CARISOPRODOL [USP MONOGRAPH] EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CARISOPRODOL [USP MONOGRAPH] to their clients by showing that a CARISOPRODOL [USP MONOGRAPH] CEP has been issued for it. The manufacturer submits a CARISOPRODOL [USP MONOGRAPH] CEP (COS) as part of the market authorization procedure, and it takes on the role of a CARISOPRODOL [USP MONOGRAPH] CEP holder for the record. Additionally, the data presented in the CARISOPRODOL [USP MONOGRAPH] CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CARISOPRODOL [USP MONOGRAPH] DMF.
A CARISOPRODOL [USP MONOGRAPH] CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CARISOPRODOL [USP MONOGRAPH] CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CARISOPRODOL [USP MONOGRAPH] suppliers with CEP (COS) on PharmaCompass.
We have 1 companies offering CARISOPRODOL [USP MONOGRAPH]
Get in contact with the supplier of your choice:
